Supplementary Figure 3 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 3079K, Supplemental Fig. 3: Paired pre-treatment versus post-vorinostat treatment biopsies from a lung cancer probed for p21 immunohistochemical expression. These representative biopsies from case 7 revealed an increase in p21 levels in the post-treatment (multiple arrows) relative to the pre-treatment lung cancer (single arrow) biopsy.
Authors: Tian Ma, Fabrizio Galimberti, Cherie P. Erkmen, Vincent Memoli, Fadzai Chinyengetere, Lorenzo Sempere, Jan H. Beumer, Bean N. Anyang, William Nugent, David Johnstone, Gregory J. Tsongalis, Jonathan M. Kurie, Hua Li, James DiRenzo, Yongli Guo, Sarah J. Freemantle, Konstantin H. Dragnev, Ethan Dmitrovsky
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362525889